Suraksha Diagnostic Limited (SURAKSHA) — Financial Results | 27 May 2026
Suraksha Diagnostic reported FY26 revenue of ₹3104.1 crores, up 23.1% YoY, with EBITDA margin at 31.73% and 1.37 million patients served. Mature centers delivered 36-37% EBITDA margins, while new centers operated at -5.5% EBITDA. The company expanded to 68 centers, planning 3 new hubs and 8 spoke centers in FY27 across Bihar, Tripura, and Jharkhand, targeting 100 centers by FY28. Capex of INR70 crores supports this growth, with genomics contributing INR1 crore in Q4 FY26. Expansion-related costs, including rentals, represent 30-40% of revenue.
About Suraksha Diagnostic Limited (SURAKSHA)
Healthcare · Healthcare · Listed on NSE
📡 Get AI alerts when SURAKSHA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SURAKSHA — Free💡 Ask AI about this filing
📊 More SURAKSHA filings
- Announcement — 28 September 2026Suraksha Diagnostic Limited announced that its trading window will close on 1 October 2026 and remai...
- 🟡 Voting Results — 24 September 2026Suraksha Diagnostic Limited held its 21st AGM on September 22, 2026 via video conference, approving ...
- 🟡 Board Meeting — 23 September 2026Suraksha Diagnostic held its 21st AGM on September 22, 2026, approving audited standalone and consol...
- 🟡 Board Meeting — 22 September 2026Suraksha Diagnostic held its 21st AGM on September 22, 2026, approving audited standalone and consol...
- 🟡 Board Meeting — 27 August 2026Suraksha Diagnostic announced its 21st Annual General Meeting will be held on 22 September 2026 via ...
🔥 Also filed on 27 May 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SURAKSHA files new disclosures
Track SURAKSHA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SURAKSHA — FreeFree account · 2 AI queries/day